SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling.

MLA

Fedele, Carmine, et al. “SHP2 Inhibition Diminishes KRASG12C Cycling and Promotes Tumor Microenvironment Remodeling.” The Journal of Experimental Medicine, vol. 218, no. 1, Jan. 2021. EBSCOhost, https://doi.org/10.1084/jem.20201414.

APA

Fedele, C., Li, S., Teng, K. W., Foster, C. J. R., Peng, D., Ran, H., Mita, P., Geer, M. J., Hattori, T., Koide, A., Wang, Y., Tang, K. H., Leinwand, J., Wang, W., Diskin, B., Deng, J., Chen, T., Dolgalev, I., Ozerdem, U., … Neel, B. G. (2021). SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling. The Journal of Experimental Medicine, 218(1). https://doi.org/10.1084/jem.20201414

Chicago

Fedele, Carmine, Shuai Li, Kai Wen Teng, Connor J R Foster, David Peng, Hao Ran, Paolo Mita, et al. 2021. “SHP2 Inhibition Diminishes KRASG12C Cycling and Promotes Tumor Microenvironment Remodeling.” The Journal of Experimental Medicine 218 (1). doi:10.1084/jem.20201414.